Single dose of psilocybin for depression shows promising results in UK's first publicly funded randomized trial
The first randomized controlled trial in the U.K. has found that a single dose of psilocybin, the active compound found in "magic mushrooms," produced significant improvements in depression compared with a placebo. This is the first publicly funded randomized trial of its kind to deliver the treatment within an NHS setting in England, and it found promising results.
We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.
